文献速递慢病防控与筛查免疫规划

类风湿关节炎治疗患者对推荐肺炎球菌疫苗接种方案的依从性:退伍军人事务人群中的回顾性队列研究

Compliance with recommended pneumococcal vaccination schedule in patients treated for rheumatoid arthritis: A retrospective cohort study in the Veterans Affairs population.
PubMed 文献 · Vaccine · 2024-01-04

该回顾性队列研究利用2010至2018年全国退伍军人事务数据,评估接受治疗的类风湿关节炎(RA)患者对PCV13和PPSV23疫苗接种的及时依从率。共纳入39,243例患者,疫苗依从比例为43.9%,未依从的主要独立危险因素包括黑人或非裔美国人种族、缺失或未知种族、缺失或未知族裔、从未结婚或丧偶、充血性心力衰竭或痴呆。作者认为提供者应识别RA患者肺炎球菌疫苗接种的障碍以提高依从性,并针对特定高风险群体定制增加疫苗接种的措施。

要点

  • 在39,243例接受治疗的RA患者中,疫苗依从比例为43.9%。
  • 黑人或非裔美国人种族、缺失或未知种族与疫苗未依从风险升高相关。
  • 从未结婚、丧偶、充血性心力衰竭或痴呆也与疫苗未依从风险升高相关。

核心结论

  • 作者认为提供者应识别RA患者肺炎球菌疫苗接种的障碍以提高依从性,并针对特定高风险群体定制增加疫苗接种的措施。

研究设计与样本

  • 回顾性队列研究,利用2010至2018年全国退伍军人事务数据,纳入年龄>18岁、诊断为RA且新启动RA治疗的患者,评估PCV13和PPSV23疫苗的及时接种依从性。
  • 采用多变量logistic回归识别因素,并用描述性统计描述这些因素的发生情况。

主要发现

  • 共纳入39,243例患者,大多数为白人(75.8%)、男性(85.4%)、接受甲氨蝶呤治疗(41.4%),平均年龄62.3岁。
  • 疫苗依从患者比例为43.9%。
  • 疫苗未依从的主要独立危险因素包括黑人或非裔美国人种族(OR 1.26,95%CI 1.19-1.34)或缺失/未知种族(OR 1.45,95%CI 1.31-1.61)、缺失/未知族裔(OR 1.21,95%CI 1.02-1.43)、从未结婚(OR 1.10,95%CI 1.02-1.19)或丧偶(OR 1.23,95%CI 1.12-1.34)、诊断为充血性心力衰竭(OR 1.10,95%CI 1.00-1.22)或痴呆(OR 1.48,95%CI 1.16-1.91)。
  • 疫苗未初种患者中未依从比例为32.1%,非初种患者中未依从比例为65.3%。

关键数值与推荐

  • 截至2022年,推荐两种肺炎球菌疫苗:13价肺炎球菌结合疫苗(PCV13)和肺炎球菌多糖疫苗(PPSV23);后推荐改为单剂20价PCV疫苗(PCV20),但部分人仍需要多次接种。

临床怎么用

  • 原文未据此给出具体临床推荐,仅指出提供者应识别RA患者肺炎球菌疫苗接种的障碍以提高依从性,并针对特定高风险群体定制增加疫苗接种的措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Invasive pneumococcal disease (IPD) is a leading cause of death. Rheumatoid arthritis (RA) patients are at risk of IPD due to immunosuppressant medications. Up until 2022, two pneumococcal vaccines, the 13-valent Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23), were recommended. Despite the recommendation change to give a single 20-valent PCV vaccine (PCV20), some still require multiple vaccinations. There is a need to identify barriers to vaccine uptake. METHODS: We conducted a retrospective cohort study to assess the on-time vaccination rates for PCV13 and PPSV23 in treated RA patients between 2010 and 2018 using national Veterans Affairs data. Patients > 18 years of age diagnosed with RA and newly initiated on RA treatment were included. Pneumococcal vaccine compliance was assessed by measuring on-time receipt of PCV13 and PPSV23 vaccinations. We identified factors using multivariate logistic regression and described the occurrence of these factors using descriptive statistics. RESULTS: A total of 39,243 patients were included in the study. Most patients were white (75.8 %), male (85.4 %), on methotrexate therapy (41.4 %). The average age was 62.3 years. The proportion of patients considered vaccine compliant is 43.9 %. The primary independent risk factors for vaccine non-compliance were black/African American race (Odds Ratio [OR] 1.26, 95 % Confidence Interval [CI] 1.19-1.34) or missing/unknown race (OR 1.45, 95 % CI 1.31-1.61), missing/unknown ethnicity (OR 1.21, 1.02-1.43), never married (OR 1.10, 95 % CI 1.02-1.19) or widowed (OR 1.23, 95 % CI 1.12-1.34), diagnosed with congestive heart failure (OR 1.10, 95 % CI 1.00-1.22), or dementia (OR 1.48, 95 % CI 1.16-1.91). The proportion of patients who were non-compliant in patients who were vaccine naïve was 32.1 % and the non-compliance rate for non-naïve patients was 65.3 %. CONCLUSIONS: Providers should identify barriers to pneumococcal vaccination in RA patients to improve compliance. Efforts to increase vaccination should be tailored to specific high-risk groups.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Alvarez CA, Hall RG, Lin S, et al. Compliance with recommended pneumococcal vaccination schedule in patients treated for rheumatoid arthritis: A retrospective cohort study in the Veterans Affairs population. Vaccine. 2024. PMID: 38177030. doi:10.1016/j.vaccine.2023.12.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。